
    
      The study was an open label, balanced, randomized, two-treatment, two-period, two
      sequence,single dose, crossover, oral bioequivalence study of Donepezil Hydrochloride tablets
      10mg of Dr. Reddy's Laboratories Limited, India comparing with that of ARICEPTÂ® (containing
      Donepezil Hydrochloride) tablets 10mg of Pfizer Inc, New York, 10017 in healthy, adult, human
      subjects under fed condition. 28 subjects are enrolled in the study, 3 subjects are withdrawn
      from the study and 25 subjects are completed the study.
    
  